Clinical Trials Update: Oct. 26, 2010
Atrial Fibrillation Rosacea Post Herpetic Neuralgia (PHN)
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
This study will evaluate the safety and effectiveness of an investigational drug in reducing the risk of atrial fibrillation. Participants will receive study drug, study-related lab tests and medical exams at no cost, and may qualify for time and travel compensation.
The research site is in Kenosha, Wisc.
This study will evaluate an investigational topical gel for redness associated with rosacea. To qualify, you must be 18 or older and be in good general health.
The research site is in New York City.
Post Herpetic Neuralgia (PHN)
This study is evaluating an investigational topical drug for post herpetic neuralgia pain. If you qualify, you will receive study-related exams and investigational drug, and may be compensated for time and travel expenses.
The research site is in Albuquerque, N.M.
Copyright 2010 ClinicalConnection.com. All rights reserved.